Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sino Biopharmaceutical
Pharma
AZ's China deals, Kailera-Hengrui—Fierce Pharma Asia
AZ signed billion-dollar licensing deals with CSPC and Sino Biopharm. Hengrui and Kaleira's oral GLP-1 reported China phase 3 results.
Angus Liu
Jul 10, 2026 8:51am
Merck, Zai Lab, Kailera-Hengrui—Fierce Pharma Asia
Apr 24, 2026 8:22am
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia
Mar 6, 2026 9:35am
Sanofi inks $1.5B deal for Sino Biopharm's novel asset
Mar 4, 2026 3:00am
Pfizer-Fosun, Zealand, China's new formulary—Fierce Pharma Asia
Dec 12, 2025 8:15am
